ACE2 and COVID-19: Given that increased visceral adiposity is a risk factor for COVID-19 severity and expression of ACE2 is upregulated in adipocytes of obese and diabetic patients infected with SARS-CoV-2 (Kruglikov and Scherer, 2020), we next studied whether mCoV-A59 infection affects adipose tissue.